Minor Small and Large Bowel Procedures DRG Reimbursement

DRG 346 encompasses minor small and large bowel procedures without a Complication or Comorbidity or Major Complication or Comorbidity, focusing on lower-complexity intestinal surgeries. Proper classification into this Diagnosis-Related Group matters because it defines the Centers for Medicare & Medicaid Services inpatient payment weight and aligns reimbursement with expected resource use.

DRG 346 Overview

DRG 346 covers minor small and large bowel surgical procedures without a Complication or Comorbidity or Major Complication or Comorbidity. It typically includes less complex resections, repairs, or procedures on the small intestine and colon where no additional documented complications raise resource use. This Diagnosis-Related Group matters for Centers for Medicare & Medicaid Services payment because it groups patients with lower expected resource consumption into a lower-weighted payment category. Accurate coding of procedures and comorbid conditions determines whether a case is classified in this Diagnosis-Related Group and influences inpatient reimbursement.

Perioperative optimization and enhanced recovery pathway studies: randomized or pragmatic trials testing multimodal perioperative care bundles (including fluid management, opioid-sparing analgesia, and early feeding protocols) in adult patients undergoing minor small or large bowel resections or appendectomy without major comorbidity. These studies focus on short-term inpatient outcomes such as postoperative ileus, length of stay, complication rates, and readmissions, addressing the acute surgical episode and immediate recovery phase. Results inform providers on protocols that reduce complications and resource use and help payers identify care models that lower inpatient costs and shorten LOS for this DRG.
Comparative effectiveness trials of minimally invasive versus open approaches for low-complexity bowel procedures: prospective cohort studies or randomized trials comparing laparoscopic, robotic-assisted, and open techniques in patients with uncomplicated pathology (e.g., elective small bowel resection for benign disease, sigmoid colectomy without infection). The research evaluates operative time, conversion rates, postoperative pain, wound and infectious complications, and short-term resource utilization, clarifying which approach yields the best balance of clinical benefit and cost in patients without CC/MCC. Payers and hospital administrators use these data to guide investment in surgical platforms and to develop procedure-level payment and quality metrics for this DRG.
Post-discharge recovery, functional outcomes, and readmission prevention studies: observational registries and interventional trials testing discharge education, remote monitoring, and early outpatient follow-up in patients discharged after minor bowel operations without complications. These studies enroll typical DRG 346 patients who are expected to have uncomplicated recoveries but remain at risk for readmissions due to dehydration, wound issues, or ileus; outcomes include 30-day readmission, patient-reported functional status, and total episode cost. Findings are relevant to providers and payers aiming to reduce avoidable readmissions and downstream costs while ensuring safe transitions from inpatient to outpatient care.

Perioperative optimization and enhanced recovery pathway studies: randomized or pragmatic trials testing multimodal perioperative care bundles (including fluid management, opioid-sparing analgesia, and early feeding protocols) in adult patients undergoing minor small or large bowel resections or appendectomy without major comorbidity. These studies focus on short-term inpatient outcomes such as postoperative ileus, length of stay, complication rates, and readmissions, addressing the acute surgical episode and immediate recovery phase. Results inform providers on protocols that reduce complications and resource use and help payers identify care models that lower inpatient costs and shorten LOS for this DRG.
Comparative effectiveness trials of minimally invasive versus open approaches for low-complexity bowel procedures: prospective cohort studies or randomized trials comparing laparoscopic, robotic-assisted, and open techniques in patients with uncomplicated pathology (e.g., elective small bowel resection for benign disease, sigmoid colectomy without infection). The research evaluates operative time, conversion rates, postoperative pain, wound and infectious complications, and short-term resource utilization, clarifying which approach yields the best balance of clinical benefit and cost in patients without CC/MCC. Payers and hospital administrators use these data to guide investment in surgical platforms and to develop procedure-level payment and quality metrics for this DRG.
Post-discharge recovery, functional outcomes, and readmission prevention studies: observational registries and interventional trials testing discharge education, remote monitoring, and early outpatient follow-up in patients discharged after minor bowel operations without complications. These studies enroll typical DRG 346 patients who are expected to have uncomplicated recoveries but remain at risk for readmissions due to dehydration, wound issues, or ileus; outcomes include 30-day readmission, patient-reported functional status, and total episode cost. Findings are relevant to providers and payers aiming to reduce avoidable readmissions and downstream costs while ensuring safe transitions from inpatient to outpatient care.

OpenPayer

Summary & Overview

Minor Small and Large Bowel Procedures without CC/MCC: Inpatient Reimbursement Overview

DRG 346 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes